Table 5

Propensity to discuss each dimension by region

Asia

N = 97

Latin Am

N = 46

ME/NA

N = 39

Aus/Can

N = 39

p value


Building capacity (%)


Science and research

51.5

50.0

56.4

46.2

0.84


Skilled nurses

50.5

41.3

51.3

38.5

0.48


Research infrastructure

29.9a

58.7b

30.8a, b

41.0a, b

0.01


National statistics

26.8a

37.0a, b

51.3a, b

56.4b

0.003


Public education

42.3

47.8

46.2

33.3

0.56


Developing evidence (%)


Study of local etiology

23.7

37.0

28.2

33.3

0.38


Personalized therapy

36.1a

82.6b

20.5a

48.7a

< 0.001


Developing guidelines

23.7a

47.8b

12.8a

51.3b

< 0.001


International networks

52.6a, b

63.0b

30.8a

66.7b

0.01


Local communication

36.1a

34.8a

10.3b

56.4a

< 0.001


Removing barriers (%)


Out-of-pocket costs

38.1a, b

47.8b

10.3c

20.5a, c

< 0.001


Disparities in access

37.1a, c

69.6b

23.1a

53.8b, c

< 0.001


High cost to payers

42.3

56.5

38.5

53.8

0.22


Early detection

45.4

50.0

46.2

41.0

0.88


Reimbursement

43.3a, b

45.7a, b

28.2b

61.5a

0.03


Promoting advocacy (%)


Patient empowerment

26.8a

39.1a, b

23.1a, b

53.8b

0.008


Managing survivorship

12.4a

17.4a

0.0b

33.3a

0.004


Quality of life

19.6

28.3

20.5

33.3

0.31


Metastatic disease

36.1

26.1

33.3

28.2

0.63


Organized advocacy

13.4a, c

43.5b

28.2c

5.1a

< 0.001


Based on the Mariscuillo multiple comparisons procedure [21,22], common superscripts a, b, c reflect paired comparisons that are not statistically different, while pairs that are statistically different do not share the same superscript.

Bridges et al. BMC Health Services Research 2011 11:227   doi:10.1186/1472-6963-11-227

Open Data